ASX - By Stock
|
RGT |
Re:
Ann: Annual Report 2020
|
|
Sparkz918
|
14 |
4.4K |
5 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
14
|
4.4K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Unmarketable Parcel Share Sale Update
|
|
Sparkz918
|
20 |
4.5K |
1 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
20
|
4.5K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Unmarketable Parcel Share Sale Update
|
|
Sparkz918
|
20 |
4.5K |
2 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
20
|
4.5K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC PHARMA DELIVERS RECORD CONSECUTIVE WEEKLY SALES GROWTH
|
|
Sparkz918
|
36 |
9.1K |
2 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
36
|
9.1K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Germany, Austria & Switzerland Distribution Agreement Signed
|
|
Sparkz918
|
36 |
13K |
1 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
36
|
13K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Germany, Austria & Switzerland Distribution Agreement Signed
|
|
Sparkz918
|
36 |
13K |
2 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
36
|
13K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: ARTEMIC HISTOLOGY ON RATS CONFIRM NO PATHOLOGICAL IMPACT
|
|
Sparkz918
|
20 |
4.9K |
4 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
20
|
4.9K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: ARTEMIC HISTOLOGY ON RATS CONFIRM NO PATHOLOGICAL IMPACT
|
|
Sparkz918
|
20 |
4.9K |
3 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
20
|
4.9K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
Sparkz918
|
29 |
10K |
1 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
29
|
10K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Patients Begin Treatment in Clinical Trial of CogniCann
|
|
Sparkz918
|
29 |
10K |
5 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
29
|
10K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTS
|
|
Sparkz918
|
72 |
21K |
1 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
72
|
21K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTS
|
|
Sparkz918
|
72 |
21K |
2 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
72
|
21K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTS
|
|
Sparkz918
|
72 |
21K |
1 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
72
|
21K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTS
|
|
Sparkz918
|
72 |
21K |
7 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
72
|
21K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTS
|
|
Sparkz918
|
72 |
21K |
7 |
03/10/20 |
03/10/20 |
ASX - By Stock
|
72
|
21K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTS
|
|
Sparkz918
|
72 |
21K |
5 |
03/10/20 |
03/10/20 |
ASX - By Stock
|
72
|
21K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: JV TO BE ESTABLISHED FOR REGISTRATION OF ARTEMIC IN RUSSIA
|
|
Sparkz918
|
60 |
16K |
5 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
60
|
16K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: JV TO BE ESTABLISHED FOR REGISTRATION OF ARTEMIC IN RUSSIA
|
|
Sparkz918
|
60 |
16K |
2 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
60
|
16K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: JV TO BE ESTABLISHED FOR REGISTRATION OF ARTEMIC IN RUSSIA
|
|
Sparkz918
|
60 |
16K |
2 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
60
|
16K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: JV TO BE ESTABLISHED FOR REGISTRATION OF ARTEMIC IN RUSSIA
|
|
Sparkz918
|
60 |
16K |
2 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
60
|
16K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: JV TO BE ESTABLISHED FOR REGISTRATION OF ARTEMIC IN RUSSIA
|
|
Sparkz918
|
60 |
16K |
7 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
60
|
16K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
4 |
22/08/20 |
22/08/20 |
ASX - By Stock
|
141
|
42K
|
4
|
|
ASX - By Stock
|
RGT Biotech |
Re:
COVID-19 Trial - Supplementary material/Thoughts
|
|
Sparkz918
|
102 |
35K |
5 |
22/08/20 |
22/08/20 |
ASX - By Stock
|
102
|
35K
|
5
|
|
ASX - By Stock
|
RGT Biotech |
Re:
COVID-19 Trial - Supplementary material/Thoughts
|
|
Sparkz918
|
102 |
35K |
4 |
22/08/20 |
22/08/20 |
ASX - By Stock
|
102
|
35K
|
4
|
|
ASX - By Stock
|
RGT Biotech |
Re:
COVID-19 Trial - Supplementary material/Thoughts
|
|
Sparkz918
|
102 |
35K |
4 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
102
|
35K
|
4
|
|
ASX - By Stock
|
RGT Biotech |
Re:
COVID-19 Trial - Supplementary material/Thoughts
|
|
Sparkz918
|
102 |
35K |
4 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
102
|
35K
|
4
|
|
ASX - By Stock
|
RGT Biotech |
Re:
COVID-19 Trial - Supplementary material/Thoughts
|
|
Sparkz918
|
102 |
35K |
6 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
102
|
35K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
4 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
42K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
0 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
42K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
0 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
42K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
3 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
42K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
0 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
42K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
1 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
42K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
1 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
42K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
5 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
42K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
2 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
42K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Interim Trial Results Meet All Primary Objectives
|
|
Sparkz918
|
141 |
42K |
6 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
141
|
42K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
Sparkz918
|
40 |
12K |
2 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
40
|
12K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
Sparkz918
|
40 |
12K |
3 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
40
|
12K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
Sparkz918
|
40 |
12K |
8 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
40
|
12K
|
8
|
|
ASX - By Stock
|
RGT |
Re:
MXC Chart
|
|
Sparkz918
|
17 |
6.5K |
0 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
17
|
6.5K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Proposed issue of Securities - MXC
|
|
Sparkz918
|
27 |
8.1K |
9 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
27
|
8.1K
|
9
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Proposed issue of Securities - MXC
|
|
Sparkz918
|
27 |
8.1K |
9 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
27
|
8.1K
|
9
|
|
ASX - By Stock
|
RGT |
Re:
Ann: STUDY CONFIRMS EFFECTIVENESS OF ARTEMIC ON HUMAN IMMUNE CELL
|
|
Sparkz918
|
129 |
52K |
3 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
129
|
52K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: STUDY CONFIRMS EFFECTIVENESS OF ARTEMIC ON HUMAN IMMUNE CELL
|
|
Sparkz918
|
129 |
52K |
8 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
129
|
52K
|
8
|
|
ASX - By Stock
|
RGT |
Re:
Ann: STUDY CONFIRMS EFFECTIVENESS OF ARTEMIC ON HUMAN IMMUNE CELL
|
|
Sparkz918
|
129 |
52K |
4 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
129
|
52K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading halt
|
|
Sparkz918
|
29 |
12K |
2 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
29
|
12K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading halt
|
|
Sparkz918
|
29 |
12K |
6 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
29
|
12K
|
6
|
|
ASX - By Stock
|
RGT |
Re:
Ann: June Quarterly Activity and Cashflow Report
|
|
Sparkz918
|
52 |
15K |
7 |
01/08/20 |
01/08/20 |
ASX - By Stock
|
52
|
15K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Ann: June Quarterly Activity and Cashflow Report
|
|
Sparkz918
|
52 |
15K |
4 |
01/08/20 |
01/08/20 |
ASX - By Stock
|
52
|
15K
|
4
|
|